Surmodics, Inc. (NASDAQ: SRDX)
Rowley Law PLLC is investigating potential securities law violations by Surmodics, Inc. (NASDAQ: SRDX) and its board of directors concerning the proposed acquisition of the company by GTCR. Stockholders will receive $43.00 for each share of Surmodics stock that they hold. The transaction is valued at approximately $627 million and is expected to close in […]